ArticleCureus2025

Colorectal Cancer With High Tumor Mutational Burden and Mesenchymal-Epithelial Transition (MET) Amplification With Hyperprogressive Disease After Pembrolizumab Treatment.

Satoru Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.